Credit: Shutterstock

Q3 snap­shot: The IPO mar­ket shows fresh signs of im­prove­ment, but the biotech crunch con­tin­ues to bite

The biotech IPO mar­ket crashed hard last year, but we’re see­ing the win­dow creak open in a steady up­ward trend in 2023 that bodes for …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE